PH31620A - Benzothiophenes for bone healing and fracture repair. - Google Patents

Benzothiophenes for bone healing and fracture repair.

Info

Publication number
PH31620A
PH31620A PH51161A PH51161A PH31620A PH 31620 A PH31620 A PH 31620A PH 51161 A PH51161 A PH 51161A PH 51161 A PH51161 A PH 51161A PH 31620 A PH31620 A PH 31620A
Authority
PH
Philippines
Prior art keywords
bone healing
fracture repair
benzothiophenes
image
hexamethyleneamino
Prior art date
Application number
PH51161A
Other languages
English (en)
Inventor
Cullinan George Joseph
Sato Masahiko
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PH31620A publication Critical patent/PH31620A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PH51161A 1994-08-22 1995-08-21 Benzothiophenes for bone healing and fracture repair. PH31620A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/294,130 US5502074A (en) 1994-08-22 1994-08-22 Benzothiophenes for bone healing and fracture repair

Publications (1)

Publication Number Publication Date
PH31620A true PH31620A (en) 1999-01-12

Family

ID=23132010

Family Applications (1)

Application Number Title Priority Date Filing Date
PH51161A PH31620A (en) 1994-08-22 1995-08-21 Benzothiophenes for bone healing and fracture repair.

Country Status (20)

Country Link
US (1) US5502074A (es)
EP (1) EP0769945B1 (es)
JP (1) JPH10504578A (es)
KR (1) KR970705385A (es)
AT (1) ATE240101T1 (es)
AU (1) AU701946B2 (es)
CA (1) CA2198012A1 (es)
CZ (1) CZ51997A3 (es)
DE (1) DE69530771T2 (es)
DK (1) DK0769945T3 (es)
ES (1) ES2197207T3 (es)
FI (1) FI970715A0 (es)
HU (1) HUT76855A (es)
IL (1) IL115016A (es)
MX (1) MX9701332A (es)
NO (1) NO970785L (es)
PH (1) PH31620A (es)
PT (1) PT769945E (es)
WO (1) WO1996005825A1 (es)
ZA (1) ZA956989B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5856340A (en) 1995-02-28 1999-01-05 Eli Lilly And Company Method of treating estrogen dependent cancers
US6465445B1 (en) 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
ES2187195T3 (es) 1998-09-11 2003-05-16 Gerhard Dr Schmidmaier Implantes biologicamente activos.
ATE301129T1 (de) 1999-05-04 2005-08-15 Strakan Int Ltd Androgen glykoside und die androgenische aktivität davon

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133814A (en) * 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4380635A (en) * 1981-04-03 1983-04-19 Eli Lilly And Company Synthesis of acylated benzothiophenes
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US5075321A (en) * 1987-03-24 1991-12-24 University Of Pennsylvania Methods of treating diseases characterized by interactions of IgG-containing immune complexes with macrophage Fc receptors using antiestrogenic benzothiophenes
DE4122484A1 (de) * 1991-07-06 1993-01-07 Teves Gmbh Alfred Schaltungsanordnung zur erkennung von radsensordefekten
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
TW303299B (es) * 1993-07-22 1997-04-21 Lilly Co Eli

Also Published As

Publication number Publication date
DE69530771T2 (de) 2004-03-11
ZA956989B (en) 1997-02-21
NO970785D0 (no) 1997-02-20
IL115016A (en) 1999-09-22
FI970715A (fi) 1997-02-20
ES2197207T3 (es) 2004-01-01
WO1996005825A1 (en) 1996-02-29
PT769945E (pt) 2003-09-30
EP0769945B1 (en) 2003-05-14
FI970715A0 (fi) 1997-02-20
AU3409795A (en) 1996-03-14
CA2198012A1 (en) 1996-02-29
AU701946B2 (en) 1999-02-11
DE69530771D1 (de) 2003-06-18
ATE240101T1 (de) 2003-05-15
HUT76855A (en) 1997-12-29
EP0769945A1 (en) 1997-05-02
JPH10504578A (ja) 1998-05-06
IL115016A0 (en) 1995-12-08
US5502074A (en) 1996-03-26
NO970785L (no) 1997-02-20
CZ51997A3 (en) 1997-08-13
KR970705385A (ko) 1997-10-09
DK0769945T3 (da) 2003-06-10
MX9701332A (es) 1997-05-31
EP0769945A4 (en) 1997-09-03

Similar Documents

Publication Publication Date Title
ZA956986B (en) Methods of inhibiting viral replication.
MX9701360A (es) Metodos para la inhibicion de la desmielinizacion y las enfermedades de la dismielinizacion.
MX9701334A (es) Metodos para inhibir la degeneracion de protesis oseas.
PH31620A (en) Benzothiophenes for bone healing and fracture repair.
MX9702148A (es) Metodos para inhibir la mitosis endometrial.
MX9701327A (es) Metodos para inhibir el cancer endometrial.
MX9701331A (es) Metodos para mantener los dientes y los huesos bucales.
MX9701359A (es) Metodos para la inhibicion de la hiperplasia endometrial primaria.
ZA956995B (en) Methods of reducing scarring in wound healing.
MX9709536A (es) Metodo para reducir el factor de transcripcion bef-1.
MX9705215A (es) Uso de 2-fenil-3-aroilbenzotiofenos para inhibir los efectos de la hormona del crecimiento.
MX9702861A (es) Metodo para inhibir las condiciones asociadas con la bradicinina.
MX9705697A (es) Metodos para reducir los niveles de calcio del suero.
MX9705537A (es) Metodos y composiciones para inhibir el efecto de los estrogenos del medio ambiente.
MX9709651A (es) Metodos para modulacion del factor de transcripcion nf-kb.